QUINORA Drug Patent Profile
✉ Email this page to a colleague
When do Quinora patents expire, and what generic alternatives are available?
Quinora is a drug marketed by Key Pharms and Schering and is included in two NDAs.
The generic ingredient in QUINORA is quinidine sulfate. There are twenty-seven drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the quinidine sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Quinora
A generic version of QUINORA was approved as quinidine sulfate by EPIC PHARMA LLC on September 26th, 1983.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for QUINORA?
- What are the global sales for QUINORA?
- What is Average Wholesale Price for QUINORA?
Summary for QUINORA
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 104 |
| Patent Applications: | 4,017 |
| DailyMed Link: | QUINORA at DailyMed |
US Patents and Regulatory Information for QUINORA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Key Pharms | QUINORA | quinidine sulfate | TABLET;ORAL | 083576-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Schering | QUINORA | quinidine sulfate | TABLET;ORAL | 085222-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
